Andrew Witty becomes new president of Efpia

Company: European Federation of Pharmaceutical Industries and Associations

Appointee: Andrew Witty

Location

Andrew Witty, the chief executive officer of GlaxoSmithKline, has become president of the European Federation of Pharmaceutical Industries and Associations (Efpia), effective 1 January 2010. Mr Witty as been Efpia vice president since 2008. He succeeds Arthur Higgins, the chief executive of Bayer HealthCare.

Mr Witty has been the GSK chief executive since May 2008. Previously he was president of GSK Pharmaceuticals Europe. He has worked for the UK multinational for 25 years.

Copyright 2009 Evernow Publishing Ltd